Followers | 199 |
Posts | 21900 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Monday, March 18, 2019 12:07:55 PM
http://wallstreetnewscast.com/mrzm-0317/
Here is a breakdown of Marizyme current pipeline products:
MB101 – Therapy for Complex Infected Wounds & Burns: Completed Phase 1 trials
MB102 – Therapy for Acute Ischemic Stroke: Nearing end of pre-clinical stage
MB103 – Therapy for Ischemic Myocardial Infarcs: Halfway through pre-clinical stage
MB104 – Therapy for Deep Vein Thrombosis: Early pre-clinical stage
Research Coverage Initiated
Ludlow Research, a small cap equity research firm based in New York City, announced it had initiated research coverage on Marizyme (MRZM) based on their unique treatment for ischemic stroke, and high retail demand for biotechnology investments.
To get a feel of the potential MRZM holds one can look at Hancock Jaffe Laboratories (NASDAQ: HJLI), which develops bioprosthetic (tissue based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI stock recently caught investors interest spiking from $1.40 to nearly $3.50 on positive earnings, and closure of funding for the company.
Portola Pharmaceuticals (NASDAQ: PTLA) is another player in this field that’s focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic diseases.
Register for Research Report Update
To receive an updated copy of Ludlow Research’s report on MRZM register online at https://ludlowresearch.com/investors
Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!
Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
Recent MRZM News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 08:05:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 08:23:06 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:05:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/13/2024 08:50:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/06/2024 09:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:55:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/29/2023 10:15:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 01:06:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 11:02:41 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/22/2023 09:36:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 09:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 11:08:53 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:27:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/24/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 01:08:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 01:15:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/18/2023 04:15:10 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/17/2023 09:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 01:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:15:29 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM